The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: Implications for multiple sclerosis

被引:36
作者
Carlson, Noel G.
Hill, Kenneth E.
Tsunoda, Ikuo
Fujinami, Robert S.
Rose, John W.
机构
[1] Univ Utah, Neurovirol Res Lab 151B, VASLCHCS, Salt Lake City, UT 84148 USA
[2] GRECC, Salt Lake City, UT 84148 USA
[3] Univ Utah, Inst Brain, Salt Lake City, UT 84112 USA
关键词
cyclooxygenase; 2; oligodendrocytes; apoptosis; Theiler's virus; MS;
D O I
10.1016/j.jneuroim.2006.01.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objective of this study was examine whether the inducible isoform of the enzyme cyclooxygenase (COX-2) was expressed in dying oligodendrocytes in the Theiler's murine encephalomyelitis virus (TMEV) induced demyelinating disease (TMEV-IDD), an experimental animal model for multiple sclerosis (MS). COX-2 is an enzyme that is tightly coupled to neuronal excitotoxic death. Since neuronal expression of COX-2 contributes to the susceptibility of neurons to excitotoxic death, we asked whether COX-2 was expressed in oligodendrocytes in MS plaques and in lesions during TMEV-IDD. COX-2 was expressed in oligodendrocytes in chronic active lesions from two MS patients. Similar pathology was present in TMEV-IDD spinal cord lesions. COX-2 was expressed in oligodendrocytes four weeks after infection with TMEV coincident with the onset of demyelination. A marker for apoptotic death, activated caspase 3, was present in a subset of oligodendrocytes that expressed COX-2. Oligodendrocyte expression of COX-2 in TMEV-IDD and MS lesions is consistent with a pathological role for this enzyme in demyelination. The presence of the cell death marker (activated caspase 3) with COX-2 in oligodendrocytes is direct evidence linking COX-2 with cell death of oligodendrocytes in these demyelinating diseases. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:21 / 31
页数:11
相关论文
共 39 条
[1]  
Andreasson KI, 2001, J NEUROSCI, V21, P8198
[2]   Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion [J].
Barnett, MH ;
Prineas, JW .
ANNALS OF NEUROLOGY, 2004, 55 (04) :458-468
[3]  
Breitner JCS, 1996, NEUROBIOL AGING, V17, P789
[4]   Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoid [J].
Carlson, NG .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 71 (01) :79-88
[5]   Synthesis and biological evaluation of 2-phenylpyran-4-ones:: A new class of orally active cyclooxygenase-2 inhibitors [J].
Caturla, F ;
Jiménez, JM ;
Godessart, N ;
Amat, M ;
Cárdenas, A ;
Soca, L ;
Beleta, J ;
Ryder, H ;
Crespo, MO .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (15) :3874-3886
[6]   Coxibs and cardiovascular disease [J].
FitzGerald, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (17) :1709-1711
[7]   Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study [J].
Graham, DJ ;
Campen, D ;
Hui, R ;
Spence, M ;
Cheetham, C ;
Levy, G ;
Shoor, S ;
Graham, D .
LANCET, 2005, 365 (9458) :475-481
[8]  
Hewett SJ, 2000, J PHARMACOL EXP THER, V293, P417
[9]   Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage [J].
Hill, KE ;
Zollinger, LV ;
Watt, HE ;
Carlson, NG ;
Rose, JW .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 151 (1-2) :171-179
[10]   Gender variations in early Theiler's virus induced demyelinating disease: differential susceptibility and effects of IL-4, IL-10 and combined IL-4 with IL-10 [J].
Hill, KE ;
Pigmans, M ;
Fujinami, RS ;
Rose, JW .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 85 (01) :44-51